- ￥4030
- biorbyt
- orb751977
- 英国
- 2025年12月05日
- ELISA, IHC-P
- Rabbit
- Human, Mouse
企业认证
相关产品推荐更多 >
CD3g Antibody抗体，orb215447，biorbyt
￥1560
DTX4 Antibody - C-terminal region : Biotin 抗体，orb2088391，Biorbyt
￥8216
phospho-beta Actin (Tyr53) Antibody (BF488) 抗体，orb1576527，Biorbyt
￥4796
STAT5B Antibody - C-terminal region : Biotin 抗体，orb2128132，Biorbyt
￥8216
ZNF555 Antibody - C-terminal region : HRP 抗体，orb2126522，Biorbyt
￥8216
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 抗体名：
TGF β Receptor II(Phospho-Ser225/250)polyclonal antibody抗体
- 抗体英文名：
TGF β Receptor II(Phospho-Ser225/250)polyclonal antibody
- 浓度：
1mg/ml
- 应用范围：
ELISA, IHC-P
- 宿主：
Rabbit
- 适应物种：
Human, Mouse
- 保质期：
6-12个月
- 抗原来源：
详询
- 目录编号：
orb751977
- 级别：
科研级
- 库存：
88
- 供应商：
biorbyt
- 标记物：
Unconjugated
- 克隆性：
Polyclonal
- 形态：
Liquid in PBS containing 50% glycerol, 0.5% rAlbumin and 0.02% sodium azide.
- 免疫原：
The antiserum was produced against synthesized peptide derived from human TGF beta Receptor II around the phosphorylation site of Ser225/250. AA range:191-240
- 规格：
50 ul
别名:TGFBR2; TGF-beta receptor type-2; TGFR-2; TGF-beta type II receptor; Transforming growth factor-beta receptor type II; TGF-beta receptor type II; TbetaR-II
免疫原：The antiserum was produced against synthesized peptide derived from human TGF beta Receptor II around the phosphorylation site of Ser225/250. AA range:191-240
分子量:~ 65 kDa
应用稀释比例：WB: 1: 500-2000, ICC: 1: 100-300, ELISA: 1: 10000
防腐剂:Liquid in PBS containing 50% glycerol, 0.5% rAlbumin and 0.02% sodium azide.
纯化:The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
保存说明:Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Pubmed:35436011
UniProt ID:P37173
Note:For research use only.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验11 Detection of TGF Type II Receptor Hotspot Mutations: The BAT-RII Assay
in the TGF-β pathway detected thus far is mutation of the type II receptor (RII) in colon cancers, particularly in tumors with defective mismatch repair or microsatellite instability (MSI) (3 –5 ). These RII mutations occur in a repetitive region of coding
Characterization of SMAD Phosphorylation and SMAD/Receptor Interaction
Signaling by transforming growth factor-(β superfamily members is initiated when ligand binds to and induces formation of a heteromeric receptor complex composed of type I and type II serine/threonine kinase receptors (reviewed in refs. 1 –
Analysis of Chondrocyte Functional Markers and Pericellular Matrix Components by Flow Cytometry
factor-β1 (TGF-β1)/TGF-β receptor II (TGF-βRII) cascades, as well as the interleukin-1α/β (IL-1α/β)/interleukin-1 receptors I and II (IL-1RI and II) systems. Catabolic enzymes that mediate extracellular matrix turnover, e.g., some matrix
技术资料暂无技术资料 索取技术资料
